These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 21182493)
21. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits tumor cell-induced platelet aggregation. Sheu JR; Lin CH; Peng HC; Teng CM; Huang TF Jpn J Cancer Res; 1993 Oct; 84(10):1062-71. PubMed ID: 8226281 [TBL] [Abstract][Full Text] [Related]
22. The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells. Chiang HS; Yang RS; Huang TF Br J Cancer; 1995 Feb; 71(2):265-70. PubMed ID: 7841039 [TBL] [Abstract][Full Text] [Related]
23. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration. Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of MCF-7 breast cancer cell-induced platelet aggregation using a combination of antiplatelet drugs. Lian L; Li W; Li ZY; Mao YX; Zhang YT; Zhao YM; Chen K; Duan WM; Tao M Oncol Lett; 2013 Feb; 5(2):675-680. PubMed ID: 23420392 [TBL] [Abstract][Full Text] [Related]
25. Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor. Xiao Z; Théroux P; Frojmovic M Thromb Haemost; 1999 Feb; 81(2):281-5. PubMed ID: 10064007 [TBL] [Abstract][Full Text] [Related]
26. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis. Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446 [TBL] [Abstract][Full Text] [Related]
28. Venous levels of shear support neutrophil-platelet adhesion and neutrophil aggregation in blood via P-selectin and beta2-integrin. Konstantopoulos K; Neelamegham S; Burns AR; Hentzen E; Kansas GS; Snapp KR; Berg EL; Hellums JD; Smith CW; McIntire LV; Simon SI Circulation; 1998 Sep; 98(9):873-82. PubMed ID: 9738642 [TBL] [Abstract][Full Text] [Related]
29. Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb/IIIa-dependent process. Pang JH; Coupland LA; Freeman C; Chong BH; Parish CR Clin Exp Metastasis; 2015 Jun; 32(5):495-505. PubMed ID: 25982688 [TBL] [Abstract][Full Text] [Related]
30. Effects of prostacyclin on tumor cell-induced platelet aggregation. Menter DG; Onoda JM; Taylor JD; Honn KV Cancer Res; 1984 Feb; 44(2):450-6. PubMed ID: 6362850 [TBL] [Abstract][Full Text] [Related]
31. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells. Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402 [TBL] [Abstract][Full Text] [Related]
32. Prasugrel reduces agonists' inducible platelet activation and leukocyte-platelet interaction more efficiently than clopidogrel. Gremmel T; Eslam RB; Koppensteiner R; Lang IM; Panzer S Cardiovasc Ther; 2013 Oct; 31(5):e40-5. PubMed ID: 23311679 [TBL] [Abstract][Full Text] [Related]
33. Different Effects of Ranibizumab and Bevacizumab on Platelet Activation Profile. Sobolewska B; Grimmel C; Gatsiou A; Sopova K; Klein J; Biedermann T; Stellos K; Ziemssen F Ophthalmologica; 2015; 234(4):195-210. PubMed ID: 26305017 [TBL] [Abstract][Full Text] [Related]
34. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion. Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490 [TBL] [Abstract][Full Text] [Related]
35. Platelet GPIIb/IIIa is activated and platelet-leukocyte coaggregates formed in vivo during hemodialysis. Kawabata K; Nakai S; Miwa M; Sugiura T; Otsuka Y; Shinzato T; Hiki Y; Tomimatsu I; Ushida Y; Hosono F; Maeda K Nephron; 2002 Apr; 90(4):391-400. PubMed ID: 11961397 [TBL] [Abstract][Full Text] [Related]
36. Plasma-dependent and -independent mechanisms of platelet aggregation induced by human tumour cell lines. Scarlett JD; Thurlow PJ; Connellan JM; Louis CJ Thromb Res; 1987 Jun; 46(5):715-26. PubMed ID: 3629545 [TBL] [Abstract][Full Text] [Related]
37. The effect of aspirin on thrombin stimulated platelet adhesion receptor expression and the role of neutrophils. Taylor ML; Ilton MK; Misso NL; Watkins DN; Hung J; Thompson PJ Br J Clin Pharmacol; 1998 Aug; 46(2):139-45. PubMed ID: 9723822 [TBL] [Abstract][Full Text] [Related]
39. Detection of Tumor Cell-Induced Platelet Aggregation and Granule Secretion. Schwarz S; Schlesinger M; Bendas G Methods Mol Biol; 2021; 2294():181-195. PubMed ID: 33742402 [TBL] [Abstract][Full Text] [Related]
40. Temporal and pharmacological characterization of angiostatin release and generation by human platelets: implications for endothelial cell migration. Radziwon-Balicka A; Moncada de la Rosa C; Zielnik B; Doroszko A; Jurasz P PLoS One; 2013; 8(3):e59281. PubMed ID: 23555012 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]